Lv4
456 积分 2023-11-06 加入
HZ-A-018, a novel inhibitor of Bruton tyrosine kinase, exerts anti-cancer activity and sensitizes 5-FU in gastric cancer cells
3天前
已完结
Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios
13天前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
15天前
已完结
Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX ‐622
18天前
已完结
Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 study
19天前
已完结
Nanobody therapeutics in autoimmune and immune-mediated inflammatory diseases: experimental insights and translational strategies
20天前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
25天前
已完结
Natural killer cell therapies
29天前
已完结
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
29天前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
1个月前
已完结
皖公网安备34019202002308
